Skip to search formSkip to main contentSkip to account menu

BETAHISTINE

Known as: 2-[2-(Methylamino)ethyl]pyridine, [2-(2-Pyridyl)ethyl]methylamine, 2-(beta-Methylaminoethyl)pyridine 
A histamine analog and H1 receptor agonist that serves as a vasodilator. It is used in MENIERE DISEASE and in vascular headaches but may exacerbate… 
National Institutes of Health

Related topics

Related topics

24 relations

Narrower (15)

AequamenBetahistin StadaBetahistin-ratiopharmBetahistine Dihydrobromide

Broader (2)

Histamine AgonistsVasodilator Agents
In Bloodagonistsanalogs & derivativesantagonists & inhibitors

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2010
Review
2010
Medical management of Ménière’s disease: a 10-year case series and review of literature
Ménière’s disease is frequent in our area. It is a disabling pathology that affects the patient’s quality of life. Its etiology… 
Review
2006
Review
2006
Betahistine: a retrospective synopsis of safety data.
Betahistine is a structural analogue of histamine that is prescribed for the treatment of vestibular disorders such as Ménière's… 
2005
2005
Involvement of histamine H1 and H2 receptors in the regulation of STAT-1 phosphorylation: inverse agonism exhibited by the receptor antagonists.
2005
2005
Excitatory effect of histamine on neuronal activity of rat globus pallidus by activation of H2 receptors in vitro
2001
2001
Betahistine inhibits food intake in rats.
Betahistine, administered intraperitoneally, decreased, in a dose-dependent manner and in a statistically significant degree… 
1996
1996
Phase transitions of rat stratum corneum lipids by an electron paramagnetic resonance study and relationship of phase states to drug penetration.
Highly Cited
1996
Highly Cited
1996
Mechanism for enhancement effect of lipid disperse system on percutaneous absorption.
To clarify the mechanism involved in the enhancement effect of lipid disperse systems (LDS) on percutaneous absorption, the… 
1996
1996
Nonpigmenting fixed drug eruption: a new case due to betahistine.
We describe a new case of a seldom reported subset of fixed drug eruption, the nonpigmenting type. Aside from their fixed nature… 
1981
1981
Betahistine in peripheral vertigo
MENIERE's disease, as described originally by Prosper Meniere in 1861, is an uncommon condition in an Ear, Nose and Throat… 
1974
1974
Orally Administered Betahistine and Regional Cerebral Blood Flow in Cerebrovascular Disease
C EREBRAL vasodilator agents have been questioned as an effective form of therapy for the stroke patient and have been considered… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)